NCT00190437

ANTEAB: a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPD

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 520 (actual)
• Sponsor: Assistance Publique - Hôpitaux de Paris · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Intensive Care Unit (ICU) admission for acute exacerbation of chronic obstructive lung disease (COLD) is a major cause of morbidity and mortality in such patients. Although bacterial of mortality in such patients. Although bacterial and or viral infections are considered as the major precipitating factor, the antibiotic strategy in this setting is unclear. The absence of overt infection remains controversial, and has not been adequately studied in patients admitted to the ICU. To assess the benefit ( or lack thereof ) of routine early systemic antibiotic therapy in patients with COLD admitted to the ICU. The primary objective of the essay is to evaluate the effectiveness of the precocious antibiotic therapy on the length of the respiratory symptoms with the admitted patients in polyvalent medical intensive care of chronic obstructive lung disease ( COLD )

Detailed description

This is a multicenter, randomised, double-blind controlled trial, comparing amoxicillin-clavulanic acid administered for 7 days to a placebo.

Conditions

• Chronic Obstructive Lung Disease (COLD)

Interventions

Type	Name	Description
DRUG	Amoxicillin-clavulanic	Amoxicillin-clavulanic

Timeline

• Start date: 2003-08-01
• Primary completion: 2006-10-01
• Completion: 2006-10-01
• First posted: 2005-09-19
• Last updated: 2011-05-02

Locations

2 sites across 1 country: France